Martin Schiller is the founder of Heligenics and executive director of UNLV‘s Nevada Institute of Personalized Medicine.

Your genes may hold clues to your optimal diet plan.

That’s what UNLV researcher Martin Schiller advocates with his new business, Food Genes and Me, a website that uses genetic data to predict how eating less or more of a certain food could help ward off disease.

Researchers at the University of Nevada, Las Vegas (UNLV) launched a public website called FoodGenesAndMe.com that uses computer software to scan users’ DNA for potential health problems and creates personalized diets to lower the risks.

If you’ve taken a genealogy test, you can now find out what medical problems your genes make you vulnerable to, and how you can change your diet to keep yourself healthy. Food Genes and Me, a startup developed by UNLV’s Nevada Institute of Personalized Medicine, offers a free service that lets you do just that.

It turns out you really are what you eat, according to UNLV scientists who have publicly launched a site that uses computer software to scan users’ DNA for potential health problems and create personalized diets that help lower the risks.

Martin Schiller’s research lab at UNLV is creating far more than just experiments. The research completed inside the Schiller Laboratory of Applied Bioinformatics has led to Schiller’s Heligenics, a startup that could help genetics testing companies shine a light on undiagnosed diseases.

With a new $11.4 million grant from the National Institutes of Health, UNLV wants to help the country move to a more data-driven approach to medicine.

This week UNLV was awarded an $11.4 million grant from the National Institute of Health to advance the university’s efforts in personalized medicine.

On May 6, the “All of Us” study started enrolling participants. This national study will be one of the largest ever examining the connection between genetics, behavior and medical outcomes, with a goal of 1 million or more participants. Anyone over the age of 18 in the U.S. can join.

A revolution is taking place in medication and the Nevada Institute of Personalized Medicine at UNLV is at the forefront.

Perhaps this was on your mind this morning when you were getting ready for work: Pressure-induced Tetrahedral to Orthombic Phase Transition in MgF2.

From injectable HIV meds via CytoDyn's PRO 140 to HIV prevention via PrEP, from subdermal implants and cellular scissors to x-ray crystallography, this has been an amazing year for medical breakthroughs in HIV. Here's a roundup of some of the hottest new advances and studies in the field.